Omeros Quarterly Cash Flow Statement
NASDAQ: OMERHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Omeros free cash flow
In the quarter ended Jun 30, 2026, Omeros generated $4.1 million of operating cash flow and spent $45,000 on capital expenditures. That left free cash flow of $4.1 million, a free-cash-flow margin of 14.4% of revenue. Omeros returned $5.7 million to shareholders through share repurchases, equal to 140% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Omeros cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 13.23M | 56.06M | 86.45M | -30.92M | -25.42M | -33.46M | -31.36M | -32.23M | -56.04M | -37.18M | -9.07M | -37.75M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | -107.04% | — |
| Depreciation & Amortization | 193.00K | 239.00K | 235.00K | 240.00K | 200.00K | 289.00K | 301.00K | 237.00K | 208.00K | 204.00K | 205.00K | 197.00K |
| Stock-Based Compensation | 1.62M | 1.89M | 1.73M | 1.94M | 2.06M | 2.45M | 2.43M | 2.64M | 2.77M | 2.66M | 2.69M | 3.23M |
| Change in Working Capital | -6.06M | -2.19M | -9.79M | 4.90M | 9.83M | -4.85M | 3.45M | -4.05M | 5.88M | -9.63M | -4.13M | 7.21M |
| Operating Cash Flow | 4.15M | -14.51M | -39.84M | -18.47M | -21.94M | -35.84M | -28.98M | -32.06M | -45.98M | -41.78M | -34.83M | -32.65M |
| Capital Expenditures | -45.00K | 0 | 0 | -11.00K | -13.00K | -41.00K | -26.00K | -1.00K | -80.00K | -58.00K | -118.00K | -33.00K |
| Investing Cash Flow | 3.40M | 28.73M | 111.55M | -6.86M | 21.30M | 38.54M | 34.95M | 36.04M | 73.15M | -61.92M | 116.24M | 57.17M |
| Share Repurchases | -5.73M | -4.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.85M | -4.65M | 0 |
| Financing Cash Flow | -7.47M | -21.98M | -64.44M | 25.82M | -1.72M | -1.84M | -4.09M | -4.58M | -26.88M | 98.43M | -104.95M | -483.00K |
| Net Change in Cash | 82.00K | -7.75M | 7.26M | 491.00K | -2.36M | 861.00K | 1.88M | -599.00K | 289.00K | -5.27M | -23.54M | 24.04M |
| Free Cash Flow | 4.10M | -14.51M | -39.84M | -18.48M | -21.95M | -35.88M | -29.01M | -32.06M | -46.06M | -41.84M | -34.94M | -32.68M |
This table shows 12 quarterly periods of Omeros's cash flow statement, from Q2 2026 back to Q3 2023, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow OMER's reporting calendar. What is a cash flow statement?